Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashhar Ali

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Headache|May 3, 2020
Delay in OnabotulinumtoxinA Treatment During the COVID-19 Pandemic-Perspectives from a Virus HotspotAshhar Ali
Headache|June 11, 2020
Headache as the Presenting Symptom in 2 Patients With COVID-19 and a History of Migraine: 2 Case ReportsJyotika Singh, Ashhar Ali
Headache|May 30, 2025
Cluster headache vs. labor: A comparative perspective on acute pain during and after deliveryJoudi Sharaf, Ashhar Ali
Headache|January 21, 2020
Coining the Pablo Picasso SyndromeRitika Suri, Ashhar Ali
Headache|March 3, 2017
Migraine With Neurological Features in a Scuba Diver With a Patent Foramen OvaleAshhar Ali, A David Rothner
Cleveland Clinic Journal of Medicine|November 6, 2015
The color purpleAbhinav Sood, Ashhar Ali, Adarsh Bhimraj
Psychosomatics|January 4, 2015
Delirium induced by a new synthetic legal intoxicating drug: phenazepamAshhar Ali, Jason M Jerry, Elias A Khawam
Clinical Neuropharmacology|December 1, 2018
New Daily Persistent Headache and OnabotulinumtoxinA TherapyAshhar Ali, Jennifer Kriegler, Stewart Tepper, et al.
Clinical Neurology and Neurosurgery|May 15, 2025
The use of onabotulinum toxin type A and other neurotoxins for the treatment of chronic migraine: An American Headache Society survey studyUtkarsh Agarwal, Kendra Hamilton, Ashhar Ali, et al.
Clinical Neuropharmacology|June 2, 2025
Clinical Features and ICHD Headache Diagnoses for Patients With Prominent Craniofacial Pain Referred by a Rhinologist to Headache SpecialistsAshhar Ali, Odei Alayyas, Jyotika Singh, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Headache|May 3, 2020
Delay in OnabotulinumtoxinA Treatment During the COVID-19 Pandemic-Perspectives from a Virus HotspotAshhar Ali
Headache|June 11, 2020
Headache as the Presenting Symptom in 2 Patients With COVID-19 and a History of Migraine: 2 Case ReportsJyotika Singh, Ashhar Ali
Headache|May 30, 2025
Cluster headache vs. labor: A comparative perspective on acute pain during and after deliveryJoudi Sharaf, Ashhar Ali
Headache|January 21, 2020
Coining the Pablo Picasso SyndromeRitika Suri, Ashhar Ali
Headache|March 3, 2017
Migraine With Neurological Features in a Scuba Diver With a Patent Foramen OvaleAshhar Ali, A David Rothner
Cleveland Clinic Journal of Medicine|November 6, 2015
The color purpleAbhinav Sood, Ashhar Ali, Adarsh Bhimraj
Psychosomatics|January 4, 2015
Delirium induced by a new synthetic legal intoxicating drug: phenazepamAshhar Ali, Jason M Jerry, Elias A Khawam
Clinical Neuropharmacology|December 1, 2018
New Daily Persistent Headache and OnabotulinumtoxinA TherapyAshhar Ali, Jennifer Kriegler, Stewart Tepper, et al.
Clinical Neurology and Neurosurgery|May 15, 2025
The use of onabotulinum toxin type A and other neurotoxins for the treatment of chronic migraine: An American Headache Society survey studyUtkarsh Agarwal, Kendra Hamilton, Ashhar Ali, et al.
Clinical Neuropharmacology|June 2, 2025
Clinical Features and ICHD Headache Diagnoses for Patients With Prominent Craniofacial Pain Referred by a Rhinologist to Headache SpecialistsAshhar Ali, Odei Alayyas, Jyotika Singh, et al.
Pageof 2